These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25322863)

  • 1. Receptor-type protein tyrosine phosphatases in cancer.
    Du Y; Grandis JR
    Chin J Cancer; 2015 Feb; 34(2):61-9. PubMed ID: 25322863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.
    Laczmanska I; Karpinski P; Bebenek M; Sedziak T; Ramsey D; Szmida E; Sasiadek MM
    J Hum Genet; 2013 Jan; 58(1):11-5. PubMed ID: 23096495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Receptor-Type Protein Tyrosine Phosphatases with Biotherapeutics: Is Outside-in Better than Inside-Out?
    Senis YA; Barr AJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor protein tyrosine phosphatases and cancer: new insights from structural biology.
    Nikolaienko RM; Agyekum B; Bouyain S
    Cell Adh Migr; 2012; 6(4):356-64. PubMed ID: 22796942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
    Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
    Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
    Wang ZC; Gao Q; Shi JY; Guo WJ; Yang LX; Liu XY; Liu LZ; Ma LJ; Duan M; Zhao YJ; Wu YN; Gao DM; Wang XY; Shi GM; Ding ZB; Ke AW; Tang QQ; Cao Y; Zhou J; Fan J
    Hepatology; 2015 Oct; 62(4):1201-14. PubMed ID: 25998839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatases in cancer: friends and foes!
    Labbé DP; Hardy S; Tremblay ML
    Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical relations of protein tyrosine phosphatase receptor type S in esophageal squamous cell carcinoma.
    Zhang G; Liu X; Wu J; Zhu Q; Zeng H; Wang T; Wang R
    Histol Histopathol; 2018 Nov; 33(11):1181-1188. PubMed ID: 29745967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of protein tyrosine phosphatases in human cancers.
    Zhao S; Sedwick D; Wang Z
    Oncogene; 2015 Jul; 34(30):3885-94. PubMed ID: 25263441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of protein tyrosine phosphatases in bone-resorbing osteoclasts.
    Shalev M; Elson A
    Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):114-123. PubMed ID: 30026076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity.
    Zikherman J; Parameswaran R; Hermiston M; Weiss A
    J Immunol; 2013 Mar; 190(6):2527-35. PubMed ID: 23396948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of receptor protein tyrosine phosphatases accompanies the reorganisation of the retina upon laser lesion.
    Besser M; Horvat-Bröcker A; Eysel UT; Faissner A
    Exp Brain Res; 2009 Sep; 198(1):37-47. PubMed ID: 19639307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-tyrosine phosphatases and cancer.
    Ostman A; Hellberg C; Böhmer FD
    Nat Rev Cancer; 2006 Apr; 6(4):307-20. PubMed ID: 16557282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of receptor-type protein tyrosine phosphatases by their C-terminal tail domains.
    Barnea M; Olender T; Bedford MT; Elson A
    Biochem Soc Trans; 2016 Oct; 44(5):1295-1303. PubMed ID: 27911712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatases, new targets for cancer therapy.
    Easty D; Gallagher W; Bennett DC
    Curr Cancer Drug Targets; 2006 Sep; 6(6):519-32. PubMed ID: 17017875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
    Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
    Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of protein tyrosine phosphatases in colorectal cancer.
    Hoekstra E; Peppelenbosch MP; Fuhler GM
    Biochim Biophys Acta; 2012 Aug; 1826(1):179-88. PubMed ID: 22521639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatases as novel targets in breast cancer therapy.
    Nunes-Xavier CE; Martín-Pérez J; Elson A; Pulido R
    Biochim Biophys Acta; 2013 Dec; 1836(2):211-26. PubMed ID: 23756181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma.
    Wallace MJ; Batt J; Fladd CA; Henderson JT; Skarnes W; Rotin D
    Nat Genet; 1999 Mar; 21(3):334-8. PubMed ID: 10080192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
    Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.